Express shipping and returns

 

G-Fit presents an exciting new addition to our service portfolio, helping to eliminate the ‘one size fits all’ approach to health and fitness. While DNA testing is a growing trend in the industry, G-Fit provides another step forward in the field of precision fitness – focussed on deploying the proven benefits of tailored exercise. Packaged as the first-ever genotype-based fitness class, it takes into account users’ unique DNA sequence, accommodating the difference in genetic profiles in relation to Power vs Endurance muscle fibres. It is designed to enable users to achieve their optimal health and fitness, by identifying what works best for them from the beginning.

Following the soft-launch earlier in March 2020 in Central London, in partnership with London fitness group 1RebelUK, G-Fit will be rolled out over the coming months in multiple cities across the country. The pioneering concept sits in perfect alignment with the company’s tradition of innovation and mission to personalise healthcare in the UK – and internationally.

Latest Stories

View all

Navigating GLP-1 Medications: Ultimate Guide for the community

Navigating GLP-1 Medications: Ultimate Guide for the community

Dr Sohaib Imtiaz our Clinical Lead and Board certified Lifestyle Medicine Doctor went live with our community. Here are some of the questions we were asked.  As the landscape of weight management medications evolves, questions arise about specific drugs, their...

Read more

Shareholders' letter | Year end 2021 updates - Rightangled

Shareholders' letter | Year end 2021 updates

The copy of an email newsletter sent by CEO Abdullah Sabyah to Rightangled investors on Christmas day (25th of December 2021), the letter covers a full overview and updates from the year-end 2021 with a business outlook to the year 2022.

Read more

Rightangled: Changing the Way We Look at DNA

Rightangled: Changing the Way We Look at DNA

According to the World Health Organisation, cardiovascular diseases (CVD) are the leading cause of deaths worldwide. An estimated 17.7 million people died from CVDs in 2015, representing 31% of all global deaths. In the UK alone, 7 million people battle with CVDs every day. Rightangled...

Read more